Board of Directors
 |
Matthew Nicosia Chairman of the Board Matthew Nicosia has served as a director of our Company since November, 2006. From 2000 to 2007, prior to joining the Company as Executive Chairman of the Board, Mr. Nicosia was the founder and Chief Executive Officer and served as a director of Dermacia, Inc. While founding Dermacia, Inc., in 2002, Mr. Nicosia, co-founded Quantum Sphere, Inc. and served as a director till 2004. Mr. Nicosia also currently sits on the Board of Directors and is a principal of Integrity, Equity, and is a director of several private companies. Mr. Nicosia received his Bachelor of Arts degree from Brigham Young University and an MBA degree from Pepperdine University. |
|
|
|
|
Dr. Tannin Fuja, PhD Director, Chief Executive Officer and Chief Scitentific Officer Dr. Tannin Fuja, PhD, serves as a director and as Chief Executive Officer of our Company. Prior to joining our company, Dr. Fuja headed the Molecular and Cell Biology Research Group at the National Center for Voice and Speech, and was a Member of the Scientific Advisory Board for Dermacia, Inc. Dr. Fuja has served as an adjunct faculty member in the Department of Speech Pathology and Audiology at the University of Iowa and in the Department of Anatomy and Cell Biology in the Roy J. and Lucille A. Carver College of Medicine Carver College of Medicine at the University of Iowa. Dr. Fuja is a Member of the UI Center on Aging and the Holden Comprehensive Cancer Center at the University of Iowa. Dr. Fuja is a former member of The International Society for Stem Cell Research and received his Bachelors of Science degree from Brigham Young University, a certificate in Human Subject Research Ethics from the University of Washington (Seattle) and his Doctorate in Biological Sciences in the Department of Developmental and Cell Biology from the University of California, Irvine. |
|
|
|
|
 |
John Gryga Director John Gryga is a former senior executive with General Electric's Medical division, and Director of Operations for RadNet where he oversaw annual revenue growth from $20 million to over $150 million. In addition to serving on Vivakor's Board of Directors, he is also President and Chairman of the Board for Apollo Enterprise Solutions. A graduate of Marquette University with a degree in Electrical Engineering, Mr. Gryga has taken a lead role in commercializing Vivakor's proprietary MRI technology, VivaSlices. Mr Gryga will also assist in the commercialization of Vivakor's VivaSight division's Digital Photorefractor (DPR) technology. |
|
|
|
|
Fritz Lin, M.D. Director Fritz Lin, M.D., is a Professor of Clinical Pathology and Interim Chairman of the Department of Pathology and Laboratory Medicine at the University of California, Irvine School of Medicine. He is also the Director of Surgical Pathology & Cytopathology at the UCI Medical Center and is a member of the Chao Family Comprehensive Cancer Center. Dr. Lin is a highly respected clinician and is recognized as a Best Doctor in America by Best Doctors, Inc., an organization that bases its selection on survey results from other physicians. Dr. Lin's research interests center on the applications of principles of molecular biology, immunohistochemistry and cytometry. He played a key role in the initial establishment of a human tissue bank where various frozen tumor tissues were stored for molecular and biological studies. |
|